Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GW PHARMACEUTICALS PLC | 778,476 | reported | 10 May 2019 | tx 21+683,184−1,361,112 |
| Oncobiologics, Inc. | 286,734 | reported | 01 Oct 2025 | tx 14+1,417,696 |
| Krystal Biotech, Inc. | 5,000 | reported | 30 Jun 2025 | tx 12+77,200−40,000 |
| ALLERGAN INC | 0 | reported | 17 Mar 2015 | tx 54+325,465.87−620,850.06 |
| Revance Therapeutics, Inc. | 0 | reported | 06 Feb 2025 | tx 20+155,129−45,106 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Oct 2025 | GRANT_AWARD | Oncobiologics, Inc. | 286,734 | 0.00 USD | deriv |
| 30 Jun 2025 | GRANT_AWARD | Krystal Biotech, Inc. | 5,000 | 0.00 USD | deriv |
| 06 Feb 2025 | OTHER | Revance Therapeutics, Inc. | 15,000 | — | |
| 04 Feb 2025 | TENDER | Revance Therapeutics, Inc. | 30,106 | 3.65 USD | |
| 01 Oct 2024 | GRANT_AWARD | Oncobiologics, Inc. | 56,636 | 0.00 USD | deriv |
| 01 Oct 2024 | GRANT_AWARD | Oncobiologics, Inc. | 71,169 | 0.00 USD | deriv |
| 30 Jun 2024 | GRANT_AWARD | Krystal Biotech, Inc. | 5,000 | 0.00 USD | deriv |
| 20 May 2024 | SALE | Krystal Biotech, Inc. | 10,930 | 163.71 USD | |
| 20 May 2024 | SALE | Krystal Biotech, Inc. | 7,090 | 164.34 USD | |
| 20 May 2024 | SALE | Krystal Biotech, Inc. | 1,980 | 165.76 USD | |
| 20 May 2024 | EXERCISE | Krystal Biotech, Inc. | 20,000 | 22.75 USD | |
| 20 May 2024 | EXERCISE | Krystal Biotech, Inc. | 20,000 | 0.00 USD | deriv |
| 01 May 2024 | GRANT_AWARD | Revance Therapeutics, Inc. | 15,000 | 0.00 USD | |
| 01 May 2024 | GRANT_AWARD | Revance Therapeutics, Inc. | 23,458 | 0.00 USD | deriv |
| 07 Mar 2024 | GRANT_AWARD | Oncobiologics, Inc. | 94,441 | 0.00 USD | deriv |
| 04 Oct 2023 | GRANT_AWARD | Oncobiologics, Inc. | 370,282 | 0.00 USD | deriv |
| 30 Jun 2023 | GRANT_AWARD | Krystal Biotech, Inc. | 6,800 | 0.00 USD | deriv |
| 03 May 2023 | GRANT_AWARD | Revance Therapeutics, Inc. | 3,534 | 0.00 USD | |
| 03 May 2023 | GRANT_AWARD | Revance Therapeutics, Inc. | 5,915 | 0.00 USD | deriv |
| 29 Mar 2023 | GRANT_AWARD | Oncobiologics, Inc. | 41,065 | 0.00 USD | deriv |
| 05 Oct 2022 | GRANT_AWARD | Oncobiologics, Inc. | 74,398 | 0.00 USD | deriv |
| 30 Jun 2022 | GRANT_AWARD | Krystal Biotech, Inc. | 6,800 | 0.00 USD | deriv |
| 04 May 2022 | GRANT_AWARD | Revance Therapeutics, Inc. | 6,059 | 0.00 USD | |
| 04 May 2022 | GRANT_AWARD | Revance Therapeutics, Inc. | 11,343 | 0.00 USD | deriv |
| 23 Mar 2022 | GRANT_AWARD | Oncobiologics, Inc. | 21,878 | 0.00 USD | deriv |